Orchid Pharma Ltd 26 May 2026 12:00 AM
Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter,
Net profit of Orchid Pharma rose 6.68% to Rs 23.78 crore in the quarter ended March 2026 as against Rs 22.29 crore during the previous quarter ended March 2025. Sales rose 0.05% to Rs 237.61 crore in the quarter ended March 2026 as against Rs 237.48 crore during the previous quarter ended March 2025.For the full year,net profit declined 79.38% to Rs 20.55 crore in the year ended March 2026 as against Rs 99.66 crore during the previous year ended March 2025. Sales declined 12.00% to Rs 811.33 crore in the year ended March 2026 as against Rs 921.93 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales237.61237.48 0 811.33921.93 -12 OPM %11.3111.78 -5.0712.71 - PBDT31.1127.97 11 63.04130.11 -52 PBT22.2519.09 17 27.5995.56 -71 NP23.7822.29 7 20.5599.66 -79 Powered by Capital Market - Live News
Orchid Pharma Ltd 20 May 2026 12:00 AM
Orchid Pharma to hold board meeting,
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 25 May 2026.
Orchid Pharma Ltd 12 Feb 2026 12:00 AM
Orchid Pharma reports consolidated net loss of Rs 12.61 crore in the December 2025 quarter,
Net loss of Orchid Pharma reported to Rs 12.61 crore in the quarter ended December 2025 as against net profit of Rs 20.78 crore during the previous quarter ended December 2024. Sales declined 4.63% to Rs 207.27 crore in the quarter ended December 2025 as against Rs 217.34 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales207.27217.34 -5 OPM %0.7512.13 - PBDT3.9931.06 -87 PBT-5.0422.45 PL NP-12.6120.78 PL Powered by Capital Market - Live News
Orchid Pharma Ltd 07 Feb 2026 12:00 AM
Orchid Pharma to conduct board meeting,
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News
Orchid Pharma Ltd 12 Nov 2025 12:00 AM
Orchid Pharma reports consolidated net loss of Rs 5.72 crore in the September 2025 quarter,
Net loss of Orchid Pharma reported to Rs 5.72 crore in the quarter ended September 2025 as against net profit of Rs 27.24 crore during the previous quarter ended September 2024. Sales declined 13.10% to Rs 193.52 crore in the quarter ended September 2025 as against Rs 222.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales193.52222.70 -13 OPM %-0.7613.62 - PBDT5.5734.53 -84 PBT-3.3325.90 PL NP-5.7227.24 PL Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now